Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Dyax Loses Genzyme As DX-88 Partner, But Still Eyes 2008 Approval

Feb 21 2007

• By Jonathan M. Block

Related Content

Dyax DX-88 Anticipated Approval Pushed Back to 2008

Sep 01 2006

Kos Could Launch Icatibant For Hereditary Angioedema In 2007

Jun 07 2006

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window